Literature DB >> 12071640

Neuromuscular pathology in hereditary gelsolin amyloidosis.

Sari Kiuru-Enari1, Hannu Somer, Anna-Maria Seppäläinen, Irma-Leena Notkola, Matti Haltia.   

Abstract

Hereditary gelsolin amyloidosis (AGel amyloidosis) is a systemic disorder reported worldwide in kindreds with a G654A or G654T gelsolin gene mutation. The clinically characteristic peripheral nerve involvement has been poorly characterized morphologically, and its pathogenesis remains unknown. We studied peripheral nerve and skeletal muscle biopsy or autopsy specimens of 35 patients with a G654A gelsolin gene mutation. Histological, immunohistochemical, and electron microscopic studies showed consistent deposition of gelsolin amyloid (AGel), particularly in the vascular walls and perineurial sheaths. Nerve roots were more severely affected than distal nerves. The amyloid deposits also displayed variable immunoreactivity for apolipoprotein E, amyloid P component, cystatin C, and alpha-smooth muscle actin. Sural nerve morphometry showed preferential age-related large myelinated nerve fiber loss and reduction of myelin sheath cross-sectional area. There was evidence of denervation atrophy and fiber type grouping in skeletal muscle. Our study shows that marked proximal nerve involvement with AGel angiopathy is an essential feature of AGel amyloidosis. The preferential large fiber loss, not generally seen in amyloid neuropathy, may be caused by ischemia due to AGel angiopathy. Deficient actin modulation by variant gelsolin in neurons and Schwann cells, however, may alter axonal transport and myelination and contribute to AGel polyneuropathy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12071640     DOI: 10.1093/jnen/61.6.565

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  18 in total

Review 1.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

Review 2.  Clinical utility of peripheral nerve biopsy.

Authors:  David Lacomis
Journal:  Curr Neurol Neurosci Rep       Date:  2005-02       Impact factor: 5.081

Review 3.  Amyloidogenesis of natively unfolded proteins.

Authors:  Vladimir N Uversky
Journal:  Curr Alzheimer Res       Date:  2008-06       Impact factor: 3.498

Review 4.  Gelsolin amyloidosis: genetics, biochemistry, pathology and possible strategies for therapeutic intervention.

Authors:  James P Solomon; Lesley J Page; William E Balch; Jeffery W Kelly
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-02-24       Impact factor: 8.250

5.  Heparin binds 8 kDa gelsolin cross-β-sheet oligomers and accelerates amyloidogenesis by hastening fibril extension.

Authors:  James P Solomon; Steve Bourgault; Evan T Powers; Jeffery W Kelly
Journal:  Biochemistry       Date:  2011-03-15       Impact factor: 3.162

6.  Formation of gelsolin amyloid fibrils in the rough endoplasmic reticulum of skeletal muscle in the gelsolin mouse model of inclusion body myositis: comparative analysis to human sporadic inclusion body myositis.

Authors:  Sergei I Bannykh; William E Balch; Jeffery W Kelly; Lesley J Page; G Diane Shelton
Journal:  Ultrastruct Pathol       Date:  2013-10       Impact factor: 1.094

7.  The 8 and 5 kDa fragments of plasma gelsolin form amyloid fibrils by a nucleated polymerization mechanism, while the 68 kDa fragment is not amyloidogenic.

Authors:  James P Solomon; Isaac T Yonemoto; Amber N Murray; Joshua L Price; Evan T Powers; William E Balch; Jeffery W Kelly
Journal:  Biochemistry       Date:  2009-12-08       Impact factor: 3.162

8.  Heparin accelerates gelsolin amyloidogenesis.

Authors:  Ji Young Suk; Fuming Zhang; William E Balch; Robert J Linhardt; Jeffery W Kelly
Journal:  Biochemistry       Date:  2006-02-21       Impact factor: 3.162

9.  Secretion of amyloidogenic gelsolin progressively compromises protein homeostasis leading to the intracellular aggregation of proteins.

Authors:  Lesley J Page; Ji Young Suk; Lyudmila Bazhenova; Sheila M Fleming; Malcolm Wood; Yun Jiang; Ling T Guo; Andrew P Mizisin; Robert Kisilevsky; G Diane Shelton; William E Balch; Jeffery W Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-19       Impact factor: 11.205

Review 10.  Protective mechanisms by cystatin C in neurodegenerative diseases.

Authors:  Sebastien Gauthier; Gurjinder Kaur; Weiqian Mi; Belen Tizon; Efrat Levy
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.